| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/16/2003 | US20030013766 Methods and pharmaceutical compositions for treatment of anti-estrogen resistant breast cancer using RXR Modulators |
| 01/16/2003 | US20030013765 Fluid therapy with l-lactate and/or pyruvate anions |
| 01/16/2003 | US20030013764 Use for a pyruvate dehydrogenase activator for the treatment of ischaemia in limbs |
| 01/16/2003 | US20030013763 Controlling blood glucose concentration |
| 01/16/2003 | US20030013762 6-methoxy-2-naphthylacetic acid prodrugs |
| 01/16/2003 | US20030013761 Use of fumaric acid derivatives for treating mitochondrial diseases |
| 01/16/2003 | US20030013760 Substituted 1-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 01/16/2003 | US20030013759 Injection fatty acid, or salt thereof, into arteries |
| 01/16/2003 | US20030013758 Wound healing agents; brain disorders; cardiovascular disorders; sleep disorders |
| 01/16/2003 | US20030013757 Aromatic dicarboxylic acid derivatives |
| 01/16/2003 | US20030013756 Hormone inhibitor; sexual disorders |
| 01/16/2003 | US20030013755 Autoinducer compounds |
| 01/16/2003 | US20030013754 Antiinflamamtory agents |
| 01/16/2003 | US20030013753 Antiserotonine agents |
| 01/16/2003 | US20030013752 Controlling dosage cycles |
| 01/16/2003 | US20030013751 Viricides; enzyme inhibitors |
| 01/16/2003 | US20030013748 Anticancer agents |
| 01/16/2003 | US20030013747 Novel substituted 1-aryl-3-heteroaryl-thioureas and substituted 1-aryl-3-heteroaryl-isothioureas as antiatherosclerotic agents |
| 01/16/2003 | US20030013746 Inhibitor to advance glycosylation endproducts |
| 01/16/2003 | US20030013745 Urazole compounds useful as anti-inflammatory agents |
| 01/16/2003 | US20030013744 3,4-diaryl thiophenes and analogs thereof having use as anti-inflammatory agents |
| 01/16/2003 | US20030013743 Anticancer agents |
| 01/16/2003 | US20030013742 Antiinflammatory agents; skin disorders |
| 01/16/2003 | US20030013740 Antidepressants |
| 01/16/2003 | US20030013739 Synergistic mixtures; side effect reduction |
| 01/16/2003 | US20030013738 Laminitis in horses |
| 01/16/2003 | US20030013737 Antimicrobial quinolone derivatives and use of the same to treat bacterial infections |
| 01/16/2003 | US20030013735 Dietetics |
| 01/16/2003 | US20030013734 Skin disorders, immunology diseases, wound healing agents, antiulcer agents |
| 01/16/2003 | US20030013733 Antihistamines, sleep disorders, central nervous system disorders |
| 01/16/2003 | US20030013732 Aryloxy-acetic acid compounds useful as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| 01/16/2003 | US20030013731 Synergistic mixtures; enhanced absorption |
| 01/16/2003 | US20030013730 Preventing diarrhea |
| 01/16/2003 | US20030013728 Inhibitors of thrombin induced platelet aggregation |
| 01/16/2003 | US20030013727 Therapy for sexual disorders |
| 01/16/2003 | US20030013726 Sleep disorders; anxiolytic agents; muscle disease |
| 01/16/2003 | US20030013724 Novel prolines as antimicrobial agents |
| 01/16/2003 | US20030013723 Novel urokinase inhibitors |
| 01/16/2003 | US20030013721 Antiinflammatory agents; immunology; cardiovascular disorders; rheumatic disorders |
| 01/16/2003 | US20030013720 Antidiabetic agents; obesity |
| 01/16/2003 | US20030013719 Ortho, meta-substituted bisaryl compounds, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them |
| 01/16/2003 | US20030013718 Phthalazine derivatives for treating inflammatory diseases |
| 01/16/2003 | US20030013717 Cyclooxygenase inhibitor |
| 01/16/2003 | US20030013716 Pyrazino-pyridazine derivatives as ligands for gaba receptors |
| 01/16/2003 | US20030013713 Compounds as PDE IV and TNF-inhibitors |
| 01/16/2003 | US20030013712 Antiinflammatory agents |
| 01/16/2003 | US20030013710 Sexual disorders |
| 01/16/2003 | US20030013709 Combination of a PTPase inhibitor and an alpha-glucosidase inhibitor |
| 01/16/2003 | US20030013708 Therapeutic heterocyclic compounds |
| 01/16/2003 | US20030013707 Enzyme inhibitor |
| 01/16/2003 | US20030013706 Autoimmune disease; antiinflammatory agents |
| 01/16/2003 | US20030013705 Novel carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists |
| 01/16/2003 | US20030013704 Adamantane derivatives |
| 01/16/2003 | US20030013703 Upregulation of type III endothelial cell nitric oxide synthase by agents that disrupt actin cytoskeletal organization |
| 01/16/2003 | US20030013702 Agents and methods for treatment of cancer |
| 01/16/2003 | US20030013701 Prevents vision defects |
| 01/16/2003 | US20030013699 Methods for treating alzheimer's disease and/or regulating levels of amyloid beta peptides in a subject |
| 01/16/2003 | US20030013698 Vanadium (IV) complexes containing catecholate ligand and having spermicidal activity |
| 01/16/2003 | US20030013697 Agonizing dimeric cell-surface receptors with a receptor binding moiety and chelating metal |
| 01/16/2003 | US20030013695 Airway alkalinization as a therapy for airway diseases |
| 01/16/2003 | US20030013694 Prostate diseases |
| 01/16/2003 | US20030013693 Method and composition for treatment of inflammatory conditions |
| 01/16/2003 | US20030013692 Methods of treating neurological disorders |
| 01/16/2003 | US20030013691 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds |
| 01/16/2003 | US20030013690 Increasing phosphorus uptake from the gut of dairy cows by supplementing 1alpha-hydroxylated vitamin D compounds |
| 01/16/2003 | US20030013689 Psychological disorders; synergistic mixture |
| 01/16/2003 | US20030013688 Synergistic combination of pravastatin and aspirin and method |
| 01/16/2003 | US20030013687 Pharmaceutical compositions and methods for treating anxiety, anxiety disorders and memory impairment using NAALADase inhibitors |
| 01/16/2003 | US20030013686 Bisphosphonate compound |
| 01/16/2003 | US20030013685 Process for increasing the egg production and strengthening the eggshells of poultry |
| 01/16/2003 | US20030013683 Using low surface tension lubricant; topical applying |
| 01/16/2003 | US20030013682 Heparins; antiutmor agents |
| 01/16/2003 | US20030013681 Complexing with galectins |
| 01/16/2003 | US20030013680 Oral administering of mucopolysaccharides |
| 01/16/2003 | US20030013678 Aqueous solution extraction from pectin |
| 01/16/2003 | US20030013676 Method and composition for prolonging the residence time of drugs in the gut |
| 01/16/2003 | US20030013675 Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases |
| 01/16/2003 | US20030013674 Gene therapy; in situ supplying of genes; nucleic acid complex |
| 01/16/2003 | US20030013668 Antiarthritic agents; inflammatory bowel disease; multiple sclerosis |
| 01/16/2003 | US20030013667 Therapeutic agent for ischemia which inhibits apoptosis under ischemic condition |
| 01/16/2003 | US20030013666 Injectable ready-to-use solutions containing an antitumor anthracycline glycoside |
| 01/16/2003 | US20030013665 Novel macrolide antibiotics |
| 01/16/2003 | US20030013663 Therapy for bacteria infections that are drug resistant |
| 01/16/2003 | US20030013660 Dioxolane analogs for improved inter-cellular delivery |
| 01/16/2003 | US20030013659 Herpes virus |
| 01/16/2003 | US20030013657 Reducing oxidation stresses; central nervous system disorders; antiinflammatory agents |
| 01/16/2003 | US20030013656 Reducing oxidation stresses; central nervous system disorders; antiinflammatory agents |
| 01/16/2003 | US20030013644 Complexing; therapy for genetic defects |
| 01/16/2003 | US20030013643 Prevention and treatment of streptococcal and staphylococcal infection |
| 01/16/2003 | US20030013640 Integrin linked kinase modulation of leukocyte trafficking |
| 01/16/2003 | US20030013639 Sleep inducing antacid composition |
| 01/16/2003 | US20030013638 P27 prevents cellular migration |
| 01/16/2003 | US20030013636 Prevent biosynthesis of galactoside |
| 01/16/2003 | US20030013635 Method for the treatment of depression by inhibition of NAALADase |
| 01/16/2003 | US20030013633 Central nervous system disorders; antidiabetic agents; dietetics; viricides; controlling enzyme |
| 01/16/2003 | US20030013164 Generating linoleic acid derivatives; obtain chemical intermediates, incubate with lipase, recover fatty acid conjugated to linoleic acid |
| 01/16/2003 | US20030013144 Detection of modulator of cancer activity; obtain sample containing biopolymers, incubate with modulator, monitor cellular response |
| 01/16/2003 | US20030013122 Methods and compositions for using MHC class II invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
| 01/16/2003 | US20030013081 Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection |
| 01/16/2003 | US20030013077 Binding to monoclonal antibodies; detection of Kaposi's sarcoma |